Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.71 | N/A |
| PEG Ratio (TTM) | -2.23 | N/A |
| P/S Ratio (TTM) | 1.63 | N/A |
| P/B Ratio (TTM) | 0.81 | N/A |
| P/FCF Ratio (TTM) | 10.76 | N/A |
| Price to 5YR AVG Earnings Ratio | 8.31 | N/A |
| Price to 5YR AVG FCF Ratio | 6.76 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.42% | N/A |
| ROE (TTM) | 5.19% | N/A |
| Net Profit Margin (TTM) | 9.75% | N/A |
| ROIC 5YR AVG | 20.62% | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.62% | 13.19% | -4.53% |
| Revenue | 18.53% | 10.28% | 1.70% |
| Net Income | -5.71% | 12.52% | -5.14% |
| Cash Flow | 44.06% | 15.83% | 1.49% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.19 | N/A |
| Quick Ratio (TTM) | 2.19 | N/A |
| D/E Ratio (TTM) | 0.45 | N/A |
| Interest Coverage (TTM) | 1.30 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.87 | N/A |
| LTL to 5YR AVG FCF | 5.06 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.62% | N/A |